Global Brine Fluid Market by Application (Oil & Gas, Medicinal, Others) by Geography - Analysis and Forecast to 2019
The report covers the analysis of the global brine market on the basis of applications and geography. The market data for these types is given with respect to volume (kilotons) and value ($million). The market of brine was estimated to be approximately $780 million in 2014 and is projected to witness a CAGR of 5% between 2014 and 2019. The data mentioned in the report is based on the global demand for brine.
The study provides the value chain analysis with respect to raw materials, manufacturers, and end-users. The value chain describes the key contributors to the materials market at different stages from product development to end use. It also presents profiles of the top players in the global brine industry.
The impact of market drivers and inhibitors and upcoming opportunities in the market are also illustrated in the report.
The global brine market is also classified based on different applications. The important applications include oil and gas, medical, and others. The oil and gas industry is the largest end-user market of brine.
The key companies operating in this market are Israel Chemicals Limited (Israel), Albemarle Corporation (U.S.), Chemtura Corporation (U.S.), Jordan Bromine Company (Jordan), Dow Chemicals (U.S.), Halliburton (U.S.), M-I SWACO, Hindustan Salts Ltd. (India), Tata Chemicals Ltd. (India), and Tetra Technologies (U.S.). These companies are consistently focusing on expanding their production capacity to achieve a competitive advantage and thereby serving the customers more effectively. Investments in expansion of plant capacities, followed by acquisitions, were the most preferred strategies by the top players in 2012 and 2013.
The rising demand from the North America region acts as a driving factor for this market. The growing oil and gas industry and increasing demand for medical services would boost the demand of brine in Asia-Pacific and Europe in coming years.
The report also presents a competitive landscape of the market, covering different strategies and developments, such as mergers & acquisitions, expansions, and agreements undertaken by the leading brine companies in recent years. Profiles of the leading market players are also included in the report.
Scope of the report
The global brine market has been covered in detail in this report. In order to provide an all-round picture, the current market demand and forecasts have also been included.
On the basis of applications:
The study provides the value chain analysis with respect to raw materials, manufacturers, and end-users. The value chain describes the key contributors to the materials market at different stages from product development to end use. It also presents profiles of the top players in the global brine industry.
The impact of market drivers and inhibitors and upcoming opportunities in the market are also illustrated in the report.
The global brine market is also classified based on different applications. The important applications include oil and gas, medical, and others. The oil and gas industry is the largest end-user market of brine.
The key companies operating in this market are Israel Chemicals Limited (Israel), Albemarle Corporation (U.S.), Chemtura Corporation (U.S.), Jordan Bromine Company (Jordan), Dow Chemicals (U.S.), Halliburton (U.S.), M-I SWACO, Hindustan Salts Ltd. (India), Tata Chemicals Ltd. (India), and Tetra Technologies (U.S.). These companies are consistently focusing on expanding their production capacity to achieve a competitive advantage and thereby serving the customers more effectively. Investments in expansion of plant capacities, followed by acquisitions, were the most preferred strategies by the top players in 2012 and 2013.
The rising demand from the North America region acts as a driving factor for this market. The growing oil and gas industry and increasing demand for medical services would boost the demand of brine in Asia-Pacific and Europe in coming years.
The report also presents a competitive landscape of the market, covering different strategies and developments, such as mergers & acquisitions, expansions, and agreements undertaken by the leading brine companies in recent years. Profiles of the leading market players are also included in the report.
Scope of the report
The global brine market has been covered in detail in this report. In order to provide an all-round picture, the current market demand and forecasts have also been included.
On the basis of applications:
- Oil and gas
- Medical
- Others
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF CLEAR BRINE FLUIDS MARKET
2.2 ARRIVING AT THE CLEAR BRINE FLUIDS MARKET SIZE
2.2.1 TOP DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 DEMAND SIDE APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
4.5 DEMAND SIDE ANALYSIS
5 CLEAR BRINE FLUIDS MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION
5.3 CLEAR BRINE FLUIDS IN MEDICAL INDUSTRY, BY REGION
6 CLEAR BRINE FLUIDS MARKET, BY REGION
6.1 INTRODUCTION
6.2 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.3 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.4 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.5 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION
7 CLEAR BRINE FLUIDS MARKET: COMPETITIVE LANDSCAPE
7.1 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS
7.4 JOINT VENTURES
7.5 AGREEMENTS
8 CLEAR BRINE FLUIDS MARKET, BY COMPANY
8.1 ISRAEL CHEMICALS LIMITED.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.1.5 MMM ANALYSIS
8.2 ALBEMARLE CORPORATION
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.2.5 MMM ANALYSIS
8.3 CHEMTURA CORPORATION
8.3.1 OVERVIEW
8.3.2 KEY OPERATIONS DATA
8.3.3 KEY FINANCIALS
8.3.4 PRODUCT AND SERVICE OFFERINGS
8.3.5 RELATED DEVELOPMENTS
8.3.6 MMM ANALYSIS
8.4 JORDAN BROMINE COMPANY
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.4.5 MMM ANALYSIS
8.5 THE DOW CHEMICAL COMPANY
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.5.5 MMM ANALYSIS
8.6 HALLIBURTON
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
8.6.5 MMM ANALYSIS
8.7 M-I SWACO
8.7.1 OVERVIEW
8.7.2 KEY FINANCIALS
8.7.3 PRODUCT AND SERVICE OFFERINGS
8.7.4 RELATED DEVELOPMENTS
8.7.5 MMM ANALYSIS
8.8 BAKER HUGHES INC.
8.8.1 OVERVIEW
8.8.2 KEY FINANCIALS
8.8.3 PRODUCT AND SERVICE OFFERINGS
8.8.4 MMM ANALYSIS
8.9 ZIRAX LIMITED
8.9.1 OVERVIEW
8.9.2 KEY FINANCIALS
8.9.3 PRODUCT AND SERVICE OFFERINGS
8.9.4 RELATED DEVELOPMENTS
8.9.5 MMM ANALYSIS
8.10 TETRA TECHNOLOGY
8.10.1 OVERVIEW
8.10.2 KEY FINANCIALS
8.10.3 PRODUCT & SERVICE OFFERINGS
8.10.4 RELATED DEVELOPMENTS
8.10.5 MMM ANALYSIS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 BRINE USAGE DATA
9.1.5 IMPACT ANALYSIS
9.1.6 TRADE ANALYSIS
9.1.7 HISTORICAL DATA AND TRENDS
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF CLEAR BRINE FLUIDS MARKET
2.2 ARRIVING AT THE CLEAR BRINE FLUIDS MARKET SIZE
2.2.1 TOP DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 DEMAND SIDE APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
4.5 DEMAND SIDE ANALYSIS
5 CLEAR BRINE FLUIDS MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION
5.3 CLEAR BRINE FLUIDS IN MEDICAL INDUSTRY, BY REGION
6 CLEAR BRINE FLUIDS MARKET, BY REGION
6.1 INTRODUCTION
6.2 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.3 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.4 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION
6.5 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION
7 CLEAR BRINE FLUIDS MARKET: COMPETITIVE LANDSCAPE
7.1 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS
7.4 JOINT VENTURES
7.5 AGREEMENTS
8 CLEAR BRINE FLUIDS MARKET, BY COMPANY
8.1 ISRAEL CHEMICALS LIMITED.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.1.5 MMM ANALYSIS
8.2 ALBEMARLE CORPORATION
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.2.5 MMM ANALYSIS
8.3 CHEMTURA CORPORATION
8.3.1 OVERVIEW
8.3.2 KEY OPERATIONS DATA
8.3.3 KEY FINANCIALS
8.3.4 PRODUCT AND SERVICE OFFERINGS
8.3.5 RELATED DEVELOPMENTS
8.3.6 MMM ANALYSIS
8.4 JORDAN BROMINE COMPANY
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.4.5 MMM ANALYSIS
8.5 THE DOW CHEMICAL COMPANY
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.5.5 MMM ANALYSIS
8.6 HALLIBURTON
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
8.6.5 MMM ANALYSIS
8.7 M-I SWACO
8.7.1 OVERVIEW
8.7.2 KEY FINANCIALS
8.7.3 PRODUCT AND SERVICE OFFERINGS
8.7.4 RELATED DEVELOPMENTS
8.7.5 MMM ANALYSIS
8.8 BAKER HUGHES INC.
8.8.1 OVERVIEW
8.8.2 KEY FINANCIALS
8.8.3 PRODUCT AND SERVICE OFFERINGS
8.8.4 MMM ANALYSIS
8.9 ZIRAX LIMITED
8.9.1 OVERVIEW
8.9.2 KEY FINANCIALS
8.9.3 PRODUCT AND SERVICE OFFERINGS
8.9.4 RELATED DEVELOPMENTS
8.9.5 MMM ANALYSIS
8.10 TETRA TECHNOLOGY
8.10.1 OVERVIEW
8.10.2 KEY FINANCIALS
8.10.3 PRODUCT & SERVICE OFFERINGS
8.10.4 RELATED DEVELOPMENTS
8.10.5 MMM ANALYSIS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 BRINE USAGE DATA
9.1.5 IMPACT ANALYSIS
9.1.6 TRADE ANALYSIS
9.1.7 HISTORICAL DATA AND TRENDS
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
LIST OF TABLES
Table 1 GLOBAL CLEAR BRINE FLUIDS PEER MARKET SIZE, 2014 (USD MN)
Table 2 GLOBAL CLEAR BRINE FLUIDS APPLICATION MARKET, 2014 (USD MN)
Table 3 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
Table 4 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (KT)
Table 5 GLOBAL CLEAR BRINE FLUIDS MARKET: DRIVERS AND INHIBITORS
Table 6 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 7 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 8 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (USD MN)
Table 9 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (KT)
Table 10 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH APPLICATION MARKETS, 2013–2019 (USD MN)
Table 11 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 12 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 13 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (USD MN)
Table 14 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (KT)
Table 15 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (USD MN)
Table 16 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (KT)
Table 17 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (USD MN)
Table 18 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (KT)
Table 19 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 20 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 21 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 22 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 23 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 24 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 25 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 26 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 27 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 28 GLOBAL CLEAR BRINE FLUIDS MARKET: MERGERS & ACQUISITIONS
Table 29 GLOBAL CLEAR BRINE FLUIDS MARKET: EXPANSIONS
Table 30 GLOBAL CLEAR BRINE FLUIDS MARKET: JOINT VENTURES
Table 31 GLOBAL CLEAR BRINE FLUIDS MARKET: AGREEMENTS
Table 32 ICL: KEY FINANCIALS, 2009-2013 (USD MN)
Table 33 ALBEMARLE: KEY FINANCIALS, 2009-2013 (USD MN)
Table 34 CHEMTURA: KEY OPERATIONS DATA, 2009-2013 (USD MN)
Table 35 CHEMTURA: KEY FINANCIALS, 2009-2013 (USD MN)
Table 36 DOW CHEMICAL COMPANY: KEY FINANCIALS, 2009-2013 (USD MN)
Table 37 HALLIBURTON: KEY FINANCIALS, 2009-2013 (USD MN)
Table 38 SCHLUMBERGER: KEY FINANCIALS, 2009-2013 (USD MN)
Table 39 BAKER HUGHES INC.: KEY FINANCIALS, 2010-2014 (USD MN)
Table 40 TETRA TECHNOLOGY: KEY FINANCIALS, 2009–2013 (USD MN)
Table 1 GLOBAL CLEAR BRINE FLUIDS PEER MARKET SIZE, 2014 (USD MN)
Table 2 GLOBAL CLEAR BRINE FLUIDS APPLICATION MARKET, 2014 (USD MN)
Table 3 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
Table 4 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (KT)
Table 5 GLOBAL CLEAR BRINE FLUIDS MARKET: DRIVERS AND INHIBITORS
Table 6 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 7 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 8 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (USD MN)
Table 9 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (KT)
Table 10 GLOBAL CLEAR BRINE FLUIDS MARKET: COMPARISON WITH APPLICATION MARKETS, 2013–2019 (USD MN)
Table 11 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 12 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 13 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (USD MN)
Table 14 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (KT)
Table 15 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (USD MN)
Table 16 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (KT)
Table 17 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (USD MN)
Table 18 GLOBAL CLEAR BRINE FLUIDS MARKET, BY REGION, 2013–2019 (KT)
Table 19 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 20 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 21 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 22 EUROPE CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 23 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 24 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 25 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Table 26 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Table 27 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 28 GLOBAL CLEAR BRINE FLUIDS MARKET: MERGERS & ACQUISITIONS
Table 29 GLOBAL CLEAR BRINE FLUIDS MARKET: EXPANSIONS
Table 30 GLOBAL CLEAR BRINE FLUIDS MARKET: JOINT VENTURES
Table 31 GLOBAL CLEAR BRINE FLUIDS MARKET: AGREEMENTS
Table 32 ICL: KEY FINANCIALS, 2009-2013 (USD MN)
Table 33 ALBEMARLE: KEY FINANCIALS, 2009-2013 (USD MN)
Table 34 CHEMTURA: KEY OPERATIONS DATA, 2009-2013 (USD MN)
Table 35 CHEMTURA: KEY FINANCIALS, 2009-2013 (USD MN)
Table 36 DOW CHEMICAL COMPANY: KEY FINANCIALS, 2009-2013 (USD MN)
Table 37 HALLIBURTON: KEY FINANCIALS, 2009-2013 (USD MN)
Table 38 SCHLUMBERGER: KEY FINANCIALS, 2009-2013 (USD MN)
Table 39 BAKER HUGHES INC.: KEY FINANCIALS, 2010-2014 (USD MN)
Table 40 TETRA TECHNOLOGY: KEY FINANCIALS, 2009–2013 (USD MN)
LIST OF FIGURES
Figure 1 GLOBAL CLEAR BRINE FLUIDS MARKET: SEGMENTATION & COVERAGE
Figure 2 CLEAR BRINE FLUIDS MARKET: INTEGRATED ECOSYSTEM
Figure 3 RESEARCH METHODOLOGY
Figure 4 TOP DOWN APPROACH
Figure 5 BOTTOM-UP APPROACH
Figure 6 DEMAND SIDE APPROACH
Figure 7 GLOBAL CLEAR BRINE FLUIDS MARKET SNAPSHOT
Figure 8 CLEAR BRINE FLUIDS MARKET: GROWTH ASPECTS
Figure 9 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2014 &. 2019
Figure 10 CLEAR BRINE FLUIDS: APPLICATION MARKET SCENARIO
Figure 11 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2014–2019 (USD MN)
Figure 12 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Figure 13 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (USD MN)
Figure 14 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (USD MN)
Figure 15 GLOBAL CLEAR BRINE FLUIDS MARKET: GROWTH ANALYSIS, BY REGION, 2014–2019 (USD MN)
Figure 16 GLOBAL CLEAR BRINE FLUIDS MARKET: GROWTH ANALYSIS, BY REGION, 2014–2019 (KT)
Figure 17 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 18 NORTH AMERICA CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 19 EUROPE CLEAR BRINE FLUIDS MARKET BY APPLICATION, 2013–2019 (USD MN)
Figure 20 EUROPE CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 21 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 22 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 23 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 24 ROW CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 25 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Figure 26 ISRAEL CHEMICALS LIMITED: REVENUE MIX, 2013 (%)
Figure 27 CONTRIBUTION OF ICL – INDUSTRIAL PRODUCT SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN)
Figure 28 ALBEMARLE: REVENUE MIX, 2013 (%)
Figure 29 ALBEMARLE: COMPANY REVENUE, 2009-2013 (USD MN)
Figure 30 CHEMTURA: REVENUE MIX, 2013 (%)
Figure 31 THE DOW CHEMICAL COMPANY: REVENUE MIX, 2013 (%)
Figure 32 THE DOW CHEMICAL COMPANY: REVENUE MIX, 2010-2013 (USD MN)
Figure 33 HALLIBURTON: REVENUE MIX, 2013 (%)
Figure 34 HALLIBURTON: TOTAL REVENUE, 2009-2013 (USD MN)
Figure 35 SCHLUMBERGER: REVENUE MIX, 2013 (%)
Figure 36 SCHLUMBERGER: REVENUE, 2009-2013 (USD MN)
Figure 37 BAKER HUGHES INC.: REVENUE MIX, 2013 (%)
Figure 38 BAKER HUGHES INC.: TOTAL REVENUE, 2009-2013 (USD MN)
Figure 39 TETRA TECHNOLOGY: REVENUE MIX, 2013 (%)
Figure 40 TETRA TECHNOLOGY, REVENUE (2009-2013)
Figure 1 GLOBAL CLEAR BRINE FLUIDS MARKET: SEGMENTATION & COVERAGE
Figure 2 CLEAR BRINE FLUIDS MARKET: INTEGRATED ECOSYSTEM
Figure 3 RESEARCH METHODOLOGY
Figure 4 TOP DOWN APPROACH
Figure 5 BOTTOM-UP APPROACH
Figure 6 DEMAND SIDE APPROACH
Figure 7 GLOBAL CLEAR BRINE FLUIDS MARKET SNAPSHOT
Figure 8 CLEAR BRINE FLUIDS MARKET: GROWTH ASPECTS
Figure 9 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2014 &. 2019
Figure 10 CLEAR BRINE FLUIDS: APPLICATION MARKET SCENARIO
Figure 11 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2014–2019 (USD MN)
Figure 12 GLOBAL CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (KT)
Figure 13 GLOBAL CLEAR BRINE FLUIDS MARKET IN OIL AND GAS, BY REGION, 2013–2019 (USD MN)
Figure 14 GLOBAL CLEAR BRINE FLUIDS MARKET IN MEDICAL INDUSTRY, BY REGION, 2013–2019 (USD MN)
Figure 15 GLOBAL CLEAR BRINE FLUIDS MARKET: GROWTH ANALYSIS, BY REGION, 2014–2019 (USD MN)
Figure 16 GLOBAL CLEAR BRINE FLUIDS MARKET: GROWTH ANALYSIS, BY REGION, 2014–2019 (KT)
Figure 17 NORTH AMERICA CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 18 NORTH AMERICA CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 19 EUROPE CLEAR BRINE FLUIDS MARKET BY APPLICATION, 2013–2019 (USD MN)
Figure 20 EUROPE CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 21 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 22 ASIA-PACIFIC CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 23 ROW CLEAR BRINE FLUIDS MARKET, BY APPLICATION, 2013–2019 (USD MN)
Figure 24 ROW CLEAR BRINE FLUIDS MARKET: APPLICATION SNAPSHOT
Figure 25 CLEAR BRINE FLUIDS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Figure 26 ISRAEL CHEMICALS LIMITED: REVENUE MIX, 2013 (%)
Figure 27 CONTRIBUTION OF ICL – INDUSTRIAL PRODUCT SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN)
Figure 28 ALBEMARLE: REVENUE MIX, 2013 (%)
Figure 29 ALBEMARLE: COMPANY REVENUE, 2009-2013 (USD MN)
Figure 30 CHEMTURA: REVENUE MIX, 2013 (%)
Figure 31 THE DOW CHEMICAL COMPANY: REVENUE MIX, 2013 (%)
Figure 32 THE DOW CHEMICAL COMPANY: REVENUE MIX, 2010-2013 (USD MN)
Figure 33 HALLIBURTON: REVENUE MIX, 2013 (%)
Figure 34 HALLIBURTON: TOTAL REVENUE, 2009-2013 (USD MN)
Figure 35 SCHLUMBERGER: REVENUE MIX, 2013 (%)
Figure 36 SCHLUMBERGER: REVENUE, 2009-2013 (USD MN)
Figure 37 BAKER HUGHES INC.: REVENUE MIX, 2013 (%)
Figure 38 BAKER HUGHES INC.: TOTAL REVENUE, 2009-2013 (USD MN)
Figure 39 TETRA TECHNOLOGY: REVENUE MIX, 2013 (%)
Figure 40 TETRA TECHNOLOGY, REVENUE (2009-2013)
